Clinical Trial Update: Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS)

View source ↗

Summary

Completed clinical trial evaluating whether biological DMARD therapy affects spinal fracture incidence in patients with ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Spinal Fracture

Snippet

Sponsor: Uppsala University | Conditions: Ankylosing Spondylitis, Spinal Fractures | Status: COMPLETED